EZH2 and neoplasm: The first was at 12 d after the introduction of tumor cells, an asymptomatic stage in which Ezh2 depletion is tumor suppressive (Fig. 2, F and G) and representing half of the median survival time in control animals (hereafter referred to as OS50).